Immediate Impact

54 standout
Sub-graph 1 of 25

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
2025 Standout
3 intermediate papers

Works of Yaobing Chen being referenced

CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer
2020

Author Peers

Author Last Decade Papers Cites
Yaobing Chen 176 88 49 120 25 365
Laura Mansi 218 88 32 81 29 352
Chunguang Guo 165 57 30 137 23 338
Michèle Orain 233 132 36 55 37 377
António Gomes 109 39 39 124 22 377
Alpaslan Özgün 210 56 26 79 27 379
Mustafa Yaylacı 177 45 34 49 25 395
Takahiro Ebata 156 99 27 148 34 391
Kartik Viswanathan 177 79 28 107 28 405
Malee Warnnissorn 107 37 65 132 31 362
Wen‐Jie Wang 167 94 28 103 34 362

All Works

Loading papers...

Rankless by CCL
2026